Ph2 study of neoadjuvant in subjects with FRa-Expressing fallopian tube or peritoneal cancer
Phase II Clinical Trial
A Single-Arm Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects with FRα-Expressing Advanced-Stage Serous Epithelial Ovarian Fallopian Tube or Primary Peritoneal Cancer(M25-231)
Participating Locations